Pharmaceutical Technology Europe, Sep 1, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Sep 1, 2012
Special Feature
Strategies for High Containment
By Patricia Van Arnum
Experts share insight on facility design and operations for high-potency manufacturing.
Editor's Comment
European Commission Investigates Pay-to-Delay Deals
By Stephanie Sutton
Following an inquiry in 2009 that suggested the launch of various generic drugs was being delayed by anticompetitive business practices, the European Commission (EC) has been closely monitoring deals for potential breaches of the EU's antitrust rules.
Industry Insider
Regulatory Intervention in Paediatric Medicines
By Nathan Jessop
Regulators in both the EU and the US have attempted to stimulate paediatric-drug development with incentives offering extended periods of patent protection, but are these actions having the desired effects?
Outsoucing Review
The Macro View
By Jim Miller
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
Ask the Expert
Tackling Tablet Sticking
Rob Blanchard and Clive Roberts discuss the issues surrounding tablet sticking.
Disposables Advisor
Pre-use Filter-Integrity Testing: To Test or Not To Test?
By Jerold Martin
There is no harmonized guidance on pre-use integrity testing of sterilizing filters, prompting discussion among users as to whether such testing is necessary.
By Stephanie Sutton
Big Pharma Placed in Malpractice Spotlight and other news from across the globe.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here